Last week, the United States Food and Drug Administration (FDA) revoked the Emergency Use Authorization for Johnson & Johnson coronavirus shots. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, noted in a Thursday letter that the FDA made the revocation at the request of Janssen Biotech, a Johnson & Johnson subsidiary, that had related that the company would not be updating its shots, the latest “lots” purchased by the US government have expired, and “there is no demand for new lots.”
The lack of demand is little surprise. Americans have increasingly became hip to the fact that Johnson & Johnson’s shots, along with those of other companies such as Moderna and Pfizer-BioNTech, are dangerous and ineffective. This is in contrast with the relentless sales pitch from shots promotors in government and media that the shots were safe and effective. Successive court decisions, followed by withdrawal of much of the remaining US coronavirus shots mandates by the Biden administration have further reduced demand by removing much of the mandates to which Americans have been subjected.
All along, Johnson & Johnson has apparently been singled out by the US government for harsher treatment than other companies engaged in the American coronavirus shots campaign. I have written about this situation in previous posts:
“FDA Says Stop the Johnson & Johnson Coronavirus Vaccine Shots” on April 13, 2021
“‘Teacher’s Pets’ Moderna and Pfizer-BioNTech Again Avoid FDA Scrutiny” on July 15, 2021
“Propaganda Master Anthony Fauci” on December 17, 2021
“FDA Again Singles Out Johnson & Johnson Coronavirus Shot for Danger Warning” on January 13, 2022
Reprinted with permission from the Ron Paul Institute for Peace and Prosperity.